

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 5mg | 180 pills | β¬1.03 | β¬232.68 β¬186.15 Best Price | |
| 5mg | 120 pills | β¬1.06 | β¬159.96 β¬127.97 | |
| 5mg | 90 pills | β¬1.27 | β¬141.78 β¬113.43 | |
| 5mg | 60 pills | β¬1.67 | β¬125.42 β¬100.34 | |
| 5mg | 30 pills | β¬2.91 | β¬109.06 β¬87.25 | |
| 10mg | 180 pills | β¬1.24 | β¬278.13 β¬222.50 Popular | |
| 10mg | 120 pills | β¬1.34 | β¬199.96 β¬159.97 | |
| 10mg | 90 pills | β¬1.48 | β¬167.23 β¬133.79 | |
| 10mg | 60 pills | β¬1.85 | β¬138.15 β¬110.52 | |
| 10mg | 30 pills | β¬3.10 | β¬116.33 β¬93.07 |
Disclaimer: This information is provided for educational purposes and should not replace professional medical advice. Always consult a healthcare professional for guidance tailored to your situation.
Why do migraine attacks sometimes feel unstoppable, and can a daily medicine truly reduce their frequency? Sibelium is a brand name for a drug called flunarizine, used mainly to prevent migraines from occurring. It belongs to a class of medicines that help stabilise brain activity so the brain is less prone to the spikes that can trigger a migraine attack.
The active ingredient in Sibelium is flunarizine. In practical terms, this medicine acts over time to lower how often migraine headaches appear and how severe they may be. For many people, the aim is to shift days with migraine from a high frequency to a lower, more manageable level, improving daily function and reducing disruption.
In Ireland, Sibelium may require a prescription depending on local rules. It is usually prescribed by a GP or a specialist such as a neurologist or a doctor who manages migraine care. This medicine is intended for preventive use, not for treating an attack once it starts.
When discussing purpose, itβs important to note that Sibelium is not an acute rescue medicine. It works best when taken consistently over weeks to months to build a protective effect against recurring migraines. Your doctor will decide whether this approach is appropriate for you based on your history and current symptoms.
Migraine is a neurological condition characterised by recurrent headaches that can be severe and disabling. Symptoms commonly include throbbing pain on one side of the head, sensitivity to light and sound, nausea, and sometimes vomiting. Some people also experience an aura, which can involve visual or sensory changes before the headache begins.
Sibelium is used as a preventive therapy for migraine, with the aim of reducing how many migraine days a person experiences. It may also help lessen the intensity and duration of migraines when they occur. It is not a medicine to take during an active attack to relieve symptoms quickly.
In some cases, people with vertigo or dizziness linked to migraine patterns may benefit from preventive treatment, including flunarizine. However, vertigo can have other causes as well, so a careful assessment is important. The medicine is chosen based on the overall pattern of symptoms and how well previous treatments have worked.
Because this medication targets migraine prevention, it is important to understand that relief from headaches might take several weeks to become noticeable. A doctor will monitor response over time and adjust plans if needed. If you have questions about whether this treatment matches your symptoms, talk to your healthcare professional.
Flunarizine works by affecting certain signals in brain cells that can become overactive in migraine. By dampening these signals, the brain becomes less prone to triggering a migraine attack. This mechanism helps reduce the frequency of headaches over time and can lower the sensory overreaction that makes migraines feel so disruptive.
The medicine also has effects on the inner ear balance system, which can contribute to dizziness or vertigo in some migraine patients. By stabilising activity in those pathways, flunarizine may lessen the chance of vertigo associated with migraines. This dual action can be helpful for people who experience multiple symptoms with their migraine pattern.
Think of it as a stabilising influence for the brainβs wiring and balance systems. It does not βcureβ migraine, but it lowers the likelihood that a person will experience a full-blown attack on any given day. The effect builds gradually as the medicine is taken consistently as prescribed.
As with all medicines, the exact way it helps each person can vary. Your healthcare professional will explain what to expect based on your medical history and how your migraines present. If you notice unexpected changes in mood, sleep, or movement while taking this drug, report them promptly.
The prescribing doctor will determine the most appropriate dose for you, balancing effectiveness with tolerability. It is essential to follow the plan they provide, rather than adapting the dose on your own. Do not change the amount or frequency without medical advice.
Typically, this type of preventive treatment is taken once daily, and many people find taking it at the same time each day helps with adherence. You can usually take it with or without food, depending on what suits you best and what your doctor recommends. If drowsiness or fatigue occurs, taking the dose in the evening might be advised.
If you miss a dose, take it as soon as you remember unless it is nearly time for your next dose. In that case, skip the missed dose and resume your regular schedule. Do not take a double dose to make up for a missed one. If you stop taking the medicine abruptly, talk to your doctor about how to taper safely.
Keep regular follow-up appointments so the clinician can assess how well the medicine is working and monitor for any side effects or interactions with other medicines. Tell your pharmacist about all other prescriptions, supplements, or over-the-counter products you use, as some substances can interact with this medicine.
Do not take Sibelium if you have a known allergy to flunarizine or any of the ingredients in the tablet. An allergic reaction could involve symptoms such as rash, itching, swelling, or trouble breathing, and would require medical attention.
This medicine is not typically recommended for children and adolescents under 18, unless a clinician specifically approves it for an individual case. The safety and effectiveness in younger people have not established the same way as for adults.
Pregnant or breastfeeding individuals should avoid this medicine unless a clinician deems it necessary and benefits outweigh risks. If you are planning pregnancy or are currently pregnant or breastfeeding, discuss alternatives with your healthcare provider.
People with significant liver disease or other serious medical conditions should discuss potential risks with a clinician before starting therapy. If you have a history of mood changes or movement-related symptoms, you should disclose this to your doctor, who can weigh the safety and appropriateness of this treatment. If there is any uncertainty about suitability, consult the official patient leaflet or a pharmacist for guidance.
Flunarizine can cause drowsiness or fatigue in some individuals, especially at the start of therapy or when the dose is adjusted. Plan activities that require alertness accordingly and avoid driving until you know how this medicine affects you. If drowsiness persists or worsens, speak with your clinician about adjusting the dose or timing.
Weight gain and increased appetite have been reported with longer courses of treatment for some patients. Regular monitoring of weight and overall health can help identify these effects early, and your clinician can offer advice on managing them. Tell your doctor if weight changes are concerning or become rapid.
As with other medicines that act on the brain, there is a theoretical risk of mood changes or depressive symptoms emerging in some individuals. If you notice persistent sadness, anxiety, or thoughts of self-harm, seek medical help promptly. In people with known psychiatric conditions, careful monitoring is recommended during treatment.
Alcohol can amplify drowsiness and other central nervous system effects. Limit or avoid alcohol while taking this medicine, and discuss any concerns with your healthcare provider. If you are using other sedating medicines, inform your clinician so they can assess cumulative effects on alertness and safety.
Common side effects include drowsiness, sleepiness, and fatigue especially at the start of therapy. Some people may also experience dry mouth, constipation, or weight changes. If these effects are bothersome or persist, talk to your doctor or pharmacist about strategies to cope.
Less common effects can involve dizziness, nausea, or a feeling of heaviness in the limbs. In rare cases, people may notice mood changes or daytime sedation that interferes with function. If you develop any persistent or unusual symptoms, seek medical advice promptly.
More serious side effects are uncommon but require urgent attention. Seek immediate medical help if you develop severe allergic reactions, movement disorders such as uncontrolled movements, breathing difficulties, or swelling of the face and throat. If you experience yellowing of the skin or eyes, dark urine, or persistent abdominal pain, contact a clinician quickly.
In the event you notice a combination of symptoms such as severe dizziness, fainting, or confusion, stop the medication and contact a healthcare professional. Your clinician will evaluate whether the symptoms are related to the medicine or to another condition and determine the proper course of action.
Some medicines and substances can interact with flunarizine and affect how well it works or increase the risk of side effects. It is important to tell your doctor about all medicines you are taking, including those obtained without a prescription and any herbal supplements. Do not start or stop other medicines without medical advice.
Alcohol can amplify drowsiness and cognitive slowing, so avoid or limit intake while using Sibelium. If you regularly consume alcohol or are planning a social event, discuss this with your clinician to ensure safety and effectiveness of the treatment plan.
Medicines that depress the central nervous system, such as certain sleep aids or anti-anxiety drugs, may have additive effects with flunarizine. Your healthcare provider may adjust dosing or suggest timing changes to reduce sedation risks. Always follow the guidance given by your prescriber and pharmacist.
Some medicines are metabolised by the same liver enzymes that process flunarizine. If you take multiple drugs that affect liver enzymes, the doctor may need to monitor you more closely and adjust therapy. Always share a complete list of medications with your healthcare team to minimise risks.
The safety of Sibelium during pregnancy has not been established in all situations. In general, this medicine is avoided during pregnancy unless a clinician determines that benefits outweigh potential risks to the unborn child. If you are pregnant or planning pregnancy, discuss options with your healthcare provider.
Breastfeeding while taking flunarizine is generally not advised because the drug can pass into breast milk. If you are breastfeeding and migraines are affecting your quality of life, talk with your clinician about alternatives or strategies that may be compatible with breastfeeding.
If you become pregnant while on treatment, contact your healthcare professional promptly. They can advise whether you should continue, modify, or stop the medication. Each case is considered individually to protect both maternal and child health.
In all scenarios, do not alter or stop the medication without consulting a clinician. They can guide you through safe options and help manage symptoms while safeguarding the pregnancy and infant if applicable.
Response times vary by person. Some people notice fewer migraine days after several weeks of consistent use, while others may take longer to observe a change. Your clinician will plan follow-ups to assess response and adjust as needed.
If you miss a dose, take it as soon as you remember unless it is near the time for the next dose. Do not double up to make up for a missed dose. If you are unsure what to do, contact your pharmacist or clinician for guidance.
Alcohol can increase drowsiness and affect coordination in some people. It is prudent to limit or avoid alcohol while using Sibelium, and to discuss any planned social occasions with your clinician.
The duration of treatment depends on your migraine pattern and response to therapy. Some people use preventive therapy for several months, while others may require longer courses. Your doctor will review the plan at regular intervals.
Long-term use may be appropriate for some patients under careful supervision. The clinician will weigh benefits against potential risks and monitor for side effects. Any decision about extended use should be made in consultation with a healthcare professional.
If you decide to stop, do so under medical guidance. Stopping suddenly could cause a return of migraine symptoms or other effects. A clinician can advise a safe plan to taper if needed.
Older adults may have different risk profiles, including sensitivity to drowsiness or weight changes. A clinician will consider age, other health conditions, and medications when deciding on treatment. Close monitoring is advised.
It is common for prevention regimens to be combined with other therapies, but specifically which combinations are safe depends on the individual. Always inform your clinician about all treatments you use, including over-the-counter products, to avoid risky interactions.
If you experience persistent or troublesome side effects, contact your healthcare professional promptly. They can assess whether the side effects are related to the medicine and decide on dose adjustments or alternatives.
Access to sibelium may depend on local rules regarding prescription medicines. In many settings, it requires a prescription or formal medical assessment. If you are unsure, speak with a pharmacist or your doctor for clarification.
Travel and schedule changes can affect adherence and tolerability. Plan ahead: maintain the daily dosing routine, consider travel time zones, and discuss any concerns with your clinician before travel. They can help you prepare and adjust if needed.
For comprehensive, patient-focused information, refer to the official patient leaflet that accompanies the medicine. This document provides detailed instructions, warnings, and practical guidance specific to the product you receive. Always read the leaflet along with your prescription label.
If you have questions, ask your pharmacist or a GP or neurologist who manages your migraine care. They can explain how Sibelium fits with your medical history and other treatments. Your healthcare team can also help you understand monitoring plans and what to do if symptoms change.
National healthcare authorities and official pharmacovigilance resources in Ireland can offer general information about safety, reporting side effects, and how to access patient support. Your pharmacist is a good point of contact if you need clarifications about the medication or its use in your local setting.
When in doubt, consult the official leaflets and your healthcare providers. They can provide personalised guidance aligned with your health status and current medications. This approach helps ensure safe, effective use of Sibelium as part of a broader migraine management plan.
14β21 days. Free from β¬172.01 .
5β9 days. β¬25.80
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.